Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HARVARD BIOSCIENCE INCHBIO · Entity 7369 | Director | January 02, 2018 | January 04, 2018 |
| TECOGEN INC.TGEN · Entity 6846 | Director | June 26, 2026 | July 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HARVARD BIOSCIENCE INC
Report date January 02, 2018 · Filed January 04, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 477,050 |
Reported balance
After 2018-01-02 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-01-02 · Grant · Acquired 9,700 · Balance 477,050 F1: Represents a deferred stock award of 9,700 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018, and are subject to continued service as a non-employee director on the applicable vesting dates. These retainer awards are granted in lieu and satisfaction of the annual cash retainer compensation to be earned by the director for his service on the Issuer's Board of Directors and its Committees during 2018. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the retainers all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of November, rounded to the nearest 100 shares. F2: Includes (a) a deferred stock award of 9,700 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018; (b) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; and (c) 436,050 shares of common stock held by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a deferred stock award of 9,700 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018, and are subject to continued service as a non-employee director on the applicable vesting dates. These retainer awards are granted in lieu and satisfaction of the annual cash retainer compensation to be earned by the director for his service on the Issuer's Board of Directors and its Committees during 2018. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the retainers all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of November, rounded to the nearest 100 shares.
F2: Includes (a) a deferred stock award of 9,700 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018; (b) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; and (c) 436,050 shares of common stock held by the Reporting Person.
TECOGEN INC.
Report date June 26, 2026 · Filed July 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.17 · Expires 2036-06-26 | Direct | 25,000 |
Reported balance
After 2026-06-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-26 · Grant · Acquired 25,000 · Balance 25,000 F1: Vests 25% per year |
Filing footnotes · ownership attribution and instrument terms
F1: Vests 25% per year
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
FLIR SYSTEMS INC
Report date May 14, 2021 · Filed May 14, 2021
Section 16 reporting ended · disclosed 2021-05-14. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2021-05-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-05-14 · Disposition to issuer · Disposed 599,383 · Balance 68,308 F1: Pursuant to the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among Teledyne Technologies Incorporated ("Teledyne"), Firework Merger Sub I, Inc. ("Merger Sub I"), Firework Merger Sub II, LLC, and FLIR Systems, Inc. ("FLIR"), Merger Sub I was merged with and into FLIR on May 14, 2021, with FLIR surviving, and immediately thereafter Merger Sub II was merged with and into FLIR, with Merger Sub II surviving. In connection therewith, each share of FLIR common stock outstanding immediately prior to the effective time of the merger of Merger Sub I with and into FLIR (the "Effective Time") was converted into the right to receive (i) $28.00 in cash and (ii) 0.0718 shares of Teledyne common stock, with any fractional shares to be paid in cash. The amount shown above represents the gross cash payment, but the actual payment will be less any applicable withholding for taxes. Row 2 · 2021-05-14 · Disposition to issuer · Disposed 68,308 · Balance 0 F2: Pursuant to the Merger Agreement, each FLIR restricted stock unit, including performance-based restricted stock units that were earned but subject to service-based vesting ("FLIR RSU") outstanding immediately prior to the Effective Time automatically vested and was cancelled and converted into the right to receive $56.00 in cash in respect of each share of FLIR common stock subject to such FLIR RSU. |
| Common StockSEC Table I · non-derivative | IndirectChildren's Trust | 0 |
Reported balance
After 2021-05-14 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2021-05-14 · Disposition to issuer · Disposed 30,000 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among Teledyne Technologies Incorporated ("Teledyne"), Firework Merger Sub I, Inc. ("Merger Sub I"), Firework Merger Sub II, LLC, and FLIR Systems, Inc. ("FLIR"), Merger Sub I was merged with and into FLIR on May 14, 2021, with FLIR surviving, and immediately thereafter Merger Sub II was merged with and into FLIR, with Merger Sub II surviving. In connection therewith, each share of FLIR common stock outstanding immediately prior to the effective time of the merger of Merger Sub I with and into FLIR (the "Effective Time") was converted into the right to receive (i) $28.00 in cash and (ii) 0.0718 shares of Teledyne common stock, with any fractional shares to be paid in cash. The amount shown above represents the gross cash payment, but the actual payment will be less any applicable withholding for taxes. |
| Common StockSEC Table I · non-derivative | IndirectSpouse | 0 |
Reported balance
After 2021-05-14 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2021-05-14 · Disposition to issuer · Disposed 176,832 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among Teledyne Technologies Incorporated ("Teledyne"), Firework Merger Sub I, Inc. ("Merger Sub I"), Firework Merger Sub II, LLC, and FLIR Systems, Inc. ("FLIR"), Merger Sub I was merged with and into FLIR on May 14, 2021, with FLIR surviving, and immediately thereafter Merger Sub II was merged with and into FLIR, with Merger Sub II surviving. In connection therewith, each share of FLIR common stock outstanding immediately prior to the effective time of the merger of Merger Sub I with and into FLIR (the "Effective Time") was converted into the right to receive (i) $28.00 in cash and (ii) 0.0718 shares of Teledyne common stock, with any fractional shares to be paid in cash. The amount shown above represents the gross cash payment, but the actual payment will be less any applicable withholding for taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of January 4, 2021 (the "Merger Agreement"), by and among Teledyne Technologies Incorporated ("Teledyne"), Firework Merger Sub I, Inc. ("Merger Sub I"), Firework Merger Sub II, LLC, and FLIR Systems, Inc. ("FLIR"), Merger Sub I was merged with and into FLIR on May 14, 2021, with FLIR surviving, and immediately thereafter Merger Sub II was merged with and into FLIR, with Merger Sub II surviving. In connection therewith, each share of FLIR common stock outstanding immediately prior to the effective time of the merger of Merger Sub I with and into FLIR (the "Effective Time") was converted into the right to receive (i) $28.00 in cash and (ii) 0.0718 shares of Teledyne common stock, with any fractional shares to be paid in cash. The amount shown above represents the gross cash payment, but the actual payment will be less any applicable withholding for taxes.
F2: Pursuant to the Merger Agreement, each FLIR restricted stock unit, including performance-based restricted stock units that were earned but subject to service-based vesting ("FLIR RSU") outstanding immediately prior to the Effective Time automatically vested and was cancelled and converted into the right to receive $56.00 in cash in respect of each share of FLIR common stock subject to such FLIR RSU.
NxStage Medical, Inc.
Report date February 21, 2019 · Filed February 25, 2019
Section 16 reporting ended · disclosed 2019-02-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 1
1 source rowRow 1 · 2019-02-21 · Disposition to issuer · Disposed 100,232 · Balance 0 F1: Disposed of under Merger Agreement with Fresenius Medical Care Holdings, Inc. in which all outstanding shares of Issuer's Common Stock were converted into the right to receive $30 per share in cash. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.16 · Expires 2024-05-21 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-02-21 · Disposition to issuer · Disposed 23,394 · Balance 0 F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.81 · Expires 2025-05-20 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-02-21 · Disposition to issuer · Disposed 19,724 · Balance 0 F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.32 · Expires 2023-05-25 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-02-21 · Disposition to issuer · Disposed 15,854 · Balance 0 F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.78 · Expires 2024-05-24 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-02-21 · Disposition to issuer · Disposed 15,643 · Balance 0 F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of under Merger Agreement with Fresenius Medical Care Holdings, Inc. in which all outstanding shares of Issuer's Common Stock were converted into the right to receive $30 per share in cash.
F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 18, 2020 Filed Aug 20, 2020 19:36 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 1,500 | $0.80 | $1,197.00 |
DisclosureSEC source: 0001537435-20-000116 · wf-form4_159795215099458.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,327 Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 19:36 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 1,827 | $0.79 | $1,442.78 |
DisclosureSEC source: 0001537435-20-000116 · wf-form4_159795215099458.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,827 Read SEC document |
| July 09, 2020 Filed Jul 21, 2020 16:11 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.71 Strike: $0.71 | $71,000.00 |
DisclosureSEC source: 0001537435-20-000096 · wf-form4_159534790061216.xml · derivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-07-09 F1 · derivative.exercise_date: 25% of options vest on each of the first four anniversaries of the grant date Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 17:59 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 17,843 | $0.90 | $16,058.70 |
DisclosureSEC source: 0001537435-20-000065 · wf-form4_159172557612040.xml · nonDerivative · entry 9 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 17:59 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 24,974 | $0.89 | $22,226.86 |
DisclosureSEC source: 0001537435-20-000065 · wf-form4_159172557612040.xml · nonDerivative · entry 8 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,157 Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 17:59 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 18,557 | $0.88 | $16,330.16 |
DisclosureSEC source: 0001537435-20-000065 · wf-form4_159172557612040.xml · nonDerivative · entry 7 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,183 Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 17:59 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 13,075 | $0.87 | $11,375.25 |
DisclosureSEC source: 0001537435-20-000065 · wf-form4_159172557612040.xml · nonDerivative · entry 6 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,626 Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 17:59 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 410 | $0.86 | $352.60 |
DisclosureSEC source: 0001537435-20-000065 · wf-form4_159172557612040.xml · nonDerivative · entry 5 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,551 Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 17:59 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 8,130 | $0.85 | $6,910.50 |
DisclosureSEC source: 0001537435-20-000065 · wf-form4_159172557612040.xml · nonDerivative · entry 4 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,141 Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 17:59 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 3,300 | $0.84 | $2,772.00 |
DisclosureSEC source: 0001537435-20-000065 · wf-form4_159172557612040.xml · nonDerivative · entry 3 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,011 Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 17:59 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 2,000 | $0.83 | $1,660.00 |
DisclosureSEC source: 0001537435-20-000065 · wf-form4_159172557612040.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,711 Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 17:59 UTC | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 11,711 | $0.82 | $9,603.02 |
DisclosureSEC source: 0001537435-20-000065 · wf-form4_159172557612040.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,711 Read SEC document |
| June 04, 2020 Filed Jun 4, 2020 14:57 UTC Amendment | TECOGEN INC. TGEN · Entity 6846 | PurchaseCommon Stock | 1,000 | $0.70 | $699.80 |
DisclosureSEC source: 0001537435-20-000057 · wf-form4a_159128261509297.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 17:43 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 17,318 | $0.72 | $12,468.96 |
DisclosureSEC source: 0001537435-20-000055 · wf-form4_159120618205963.xml · nonDerivative · entry 11 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,070 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 17:43 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 1,900 | $0.72 | $1,367.62 |
DisclosureSEC source: 0001537435-20-000055 · wf-form4_159120618205963.xml · nonDerivative · entry 10 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,752 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 17:43 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 25 | $0.72 | $17.88 |
DisclosureSEC source: 0001537435-20-000055 · wf-form4_159120618205963.xml · nonDerivative · entry 9 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,852 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 17:43 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 22,617 | $0.71 | $16,058.07 |
DisclosureSEC source: 0001537435-20-000055 · wf-form4_159120618205963.xml · nonDerivative · entry 8 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,827 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 17:43 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 1,800 | $0.71 | $1,277.82 |
DisclosureSEC source: 0001537435-20-000055 · wf-form4_159120618205963.xml · nonDerivative · entry 7 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,210 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 17:43 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 3,299 | $0.71 | $2,329.09 |
DisclosureSEC source: 0001537435-20-000055 · wf-form4_159120618205963.xml · nonDerivative · entry 6 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,410 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 17:43 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 315 | $0.71 | $222.08 |
DisclosureSEC source: 0001537435-20-000055 · wf-form4_159120618205963.xml · nonDerivative · entry 5 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,111 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 17:43 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 100 | $0.70 | $70.05 |
DisclosureSEC source: 0001537435-20-000055 · wf-form4_159120618205963.xml · nonDerivative · entry 4 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,796 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 17:43 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 20,896 | $0.70 | $14,627.20 |
DisclosureSEC source: 0001537435-20-000055 · wf-form4_159120618205963.xml · nonDerivative · entry 3 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,696 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 17:43 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 30,800 | $0.70 | $21,556.92 |
DisclosureSEC source: 0001537435-20-000055 · wf-form4_159120618205963.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,800 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 17:43 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 1,000 | $0.70 | $699.80 |
DisclosureSEC source: 0001537435-20-000055 · wf-form4_159120618205963.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| June 01, 2020 Filed Jun 4, 2020 14:57 UTC Amendment | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 17,318 | $0.72 | $12,468.96 |
DisclosureSEC source: 0001537435-20-000057 · wf-form4a_159128261509297.xml · nonDerivative · entry 11 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Read SEC document |
| June 01, 2020 Filed Jun 4, 2020 14:57 UTC Amendment | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 1,900 | $0.07 | $136.80 |
DisclosureSEC source: 0001537435-20-000057 · wf-form4a_159128261509297.xml · nonDerivative · entry 10 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,682 Read SEC document |
| June 01, 2020 Filed Jun 4, 2020 14:57 UTC Amendment | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 25 | $0.72 | $17.88 |
DisclosureSEC source: 0001537435-20-000057 · wf-form4a_159128261509297.xml · nonDerivative · entry 9 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,782 Read SEC document |
| June 01, 2020 Filed Jun 4, 2020 14:57 UTC Amendment | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 22,617 | $0.71 | $16,058.07 |
DisclosureSEC source: 0001537435-20-000057 · wf-form4a_159128261509297.xml · nonDerivative · entry 8 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,757 Read SEC document |
| June 01, 2020 Filed Jun 4, 2020 14:57 UTC Amendment | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 1,800 | $0.71 | $1,277.82 |
DisclosureSEC source: 0001537435-20-000057 · wf-form4a_159128261509297.xml · nonDerivative · entry 7 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,140 Read SEC document |
| June 01, 2020 Filed Jun 4, 2020 14:57 UTC Amendment | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 3,229 | $0.71 | $2,279.67 |
DisclosureSEC source: 0001537435-20-000057 · wf-form4a_159128261509297.xml · nonDerivative · entry 6 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,340 Read SEC document |
| June 01, 2020 Filed Jun 4, 2020 14:57 UTC Amendment | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 315 | $0.71 | $222.08 |
DisclosureSEC source: 0001537435-20-000057 · wf-form4a_159128261509297.xml · nonDerivative · entry 5 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,111 Read SEC document |
| June 01, 2020 Filed Jun 4, 2020 14:57 UTC Amendment | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 100 | $0.70 | $70.05 |
DisclosureSEC source: 0001537435-20-000057 · wf-form4a_159128261509297.xml · nonDerivative · entry 4 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,796 Read SEC document |
| June 01, 2020 Filed Jun 4, 2020 14:57 UTC Amendment | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 20,896 | $0.70 | $14,627.20 |
DisclosureSEC source: 0001537435-20-000057 · wf-form4a_159128261509297.xml · nonDerivative · entry 3 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,696 Read SEC document |
| June 01, 2020 Filed Jun 4, 2020 14:57 UTC Amendment | TECOGEN INC. TGEN · Entity 6846 | GrantCommon Stock | 30,800 | $0.70 | $21,556.92 |
DisclosureSEC source: 0001537435-20-000057 · wf-form4a_159128261509297.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,800 Read SEC document |
| May 05, 2020 Filed May 6, 2020 07:54 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000354908-20-000063 · wf-form4_158876604355329.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 531,069 F1 · shares: This is a special grant to the non-executive chairman of restricted stock units expected to vest as to (i) 30,000 shares on June 1, 2020, (ii) 20,000 shares on each of September 1, 2020 and December 1, 2020 and (iii) 10,000 shares on March 1, 2021. F2 · balance_after: Includes dividends on vested restricted stock units. Read SEC document |
| March 03, 2020 Filed Jan 22, 2021 08:15 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | GiftCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000354908-21-000003 · wf-form5_161132130152234.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Children's Trust Disclosed balance after: 30,000 Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 19:21 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000354908-19-000102 · wf-form4_157360444771923.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,620 F1 · price: This transaction represents a gift / charitable donation effective November 8, 2019. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares Read SEC document |
| November 05, 2019 Filed Nov 6, 2019 20:38 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | SaleCommon Stock | 23,585 | $53.57 | $1,263,448.45 |
DisclosureSEC source: 0000354908-19-000101 · wf-form4_157309069283317.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 460,620 F1 · balance_after: Includes dividends on vested restricted stock units. Read SEC document |
| April 29, 2019 Filed May 1, 2019 14:02 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | SaleCommon Stock | 10,000 | $52.48 | $524,800.00 |
DisclosureSEC source: 0000354908-19-000060 · wf-form4_155673376441193.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 176,832 Read SEC document |
| April 26, 2019 Filed Apr 30, 2019 16:30 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | SaleCommon Stock | 23,116 | $51.33 | $1,186,544.28 |
DisclosureSEC source: 0000354908-19-000053 · wf-form4_155665620487591.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 484,031 Read SEC document |
| April 26, 2019 Filed Apr 30, 2019 16:30 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | GrantCommon Stock | 3,145 | $0.00 | $0.00 |
DisclosureSEC source: 0000354908-19-000053 · wf-form4_155665620487591.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 507,147 F1 · shares: This is a grant of restricted stock units expected to vest on 4/17/2020. F2 · balance_after: Includes dividends on vested restricted stock units. Read SEC document |
| April 26, 2019 Filed Feb 11, 2020 16:11 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | GiftCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000354908-20-000002 · wf-form5_158145546386717.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Children's Trust Disclosed balance after: 50,000 Read SEC document |
| March 01, 2019 Filed Mar 1, 2019 19:25 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 100,000 | $0.00 Strike: $30.27 | $0.00 |
DisclosureSEC source: 0000354908-19-000020 · wf-form4_155148631015458.xml · derivative · entry 5 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2020-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 1, 2019 19:25 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | SaleCommon Stock | 100,000 | $51.37 | $5,137,000.00 |
DisclosureSEC source: 0000354908-19-000020 · wf-form4_155148631015458.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 503,783 Read SEC document |
| March 01, 2019 Filed Mar 1, 2019 19:25 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | Exercise / conversionCommon Stock | 100,000 | $30.27 | $3,027,000.00 |
DisclosureSEC source: 0000354908-19-000020 · wf-form4_155148631015458.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 27, 2019 16:49 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 132,100 | $0.00 Strike: $30.27 | $0.00 |
DisclosureSEC source: 0000354908-19-000017 · wf-form4_155130413432806.xml · derivative · entry 5 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 132,100 shares Expires 2020-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 27, 2019 16:49 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | SaleCommon Stock | 132,100 | $52.11 | $6,883,731.00 |
DisclosureSEC source: 0000354908-19-000017 · wf-form4_155130413432806.xml · nonDerivative · entry 2 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 503,783 F1 · balance_after: Includes dividends on vested restricted stock units. Read SEC document |
| February 26, 2019 Filed Feb 27, 2019 16:49 UTC | FLIR SYSTEMS INC FLIR · Entity 139418 | Exercise / conversionCommon Stock | 132,100 | $30.27 | $3,998,667.00 |
DisclosureSEC source: 0000354908-19-000017 · wf-form4_155130413432806.xml · nonDerivative · entry 1 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 635,487 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 20:56 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Disposition to issuerStock Option (Right to Buy) · Derivative | 15,643 | $0.00 Strike: $22.78 | $0.00 |
DisclosureSEC source: 0001246360-19-000743 · form.xml · derivative · entry 5 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,643 shares Expires 2024-05-24 F2 · kind: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 20:56 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Disposition to issuerStock Option (Right to Buy) · Derivative | 15,854 | $0.00 Strike: $18.32 | $0.00 |
DisclosureSEC source: 0001246360-19-000743 · form.xml · derivative · entry 4 LEWIS EARL R · CIK 0001230427 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,854 shares Expires 2023-05-25 F2 · kind: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.